These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 19187006)

  • 1. Different redox states in malignant and nonmalignant esophageal epithelial cells and differential cytotoxic responses to bile acid and honokiol.
    Chen G; Izzo J; Demizu Y; Wang F; Guha S; Wu X; Hung MC; Ajani JA; Huang P
    Antioxid Redox Signal; 2009 May; 11(5):1083-95. PubMed ID: 19187006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. mTOR signaling pathway is inhibited downstream of the cyclophilin D-mediated mitochondrial permeability transition in honokiol-triggered regulated necrosis.
    Tian W; Xiong J; Zhu S; Xu D; Shen H; Deng Y
    Mol Med Rep; 2016 Apr; 13(4):3227-35. PubMed ID: 26936128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bile acid exposure up-regulates tuberous sclerosis complex 1/mammalian target of rapamycin pathway in Barrett's-associated esophageal adenocarcinoma.
    Yen CJ; Izzo JG; Lee DF; Guha S; Wei Y; Wu TT; Chen CT; Kuo HP; Hsu JM; Sun HL; Chou CK; Buttar NS; Wang KK; Huang P; Ajani J; Hung MC
    Cancer Res; 2008 Apr; 68(8):2632-40. PubMed ID: 18413730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Honokiol induces a necrotic cell death through the mitochondrial permeability transition pore.
    Li L; Han W; Gu Y; Qiu S; Lu Q; Jin J; Luo J; Hu X
    Cancer Res; 2007 May; 67(10):4894-903. PubMed ID: 17510419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclophilin D modulates cell death transition from early apoptosis to programmed necrosis induced by honokiol.
    Tian W; Xu D; Han W; He H; Cai H; Chen H; Zhou M; Chen J; Deng YC
    Int J Oncol; 2013 May; 42(5):1654-63. PubMed ID: 23525116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of oxidant production in esophageal squamous cell and Barrett's cell lines.
    Feagins LA; Zhang HY; Zhang X; Hormi-Carver K; Thomas T; Terada LS; Spechler SJ; Souza RF
    Am J Physiol Gastrointest Liver Physiol; 2008 Feb; 294(2):G411-7. PubMed ID: 18063706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Honokiol inhibits hepatoma carcinoma cell migration through downregulated Cyclophilin B expression.
    Lee YS; Jeong S; Kim KY; Yoon JS; Kim S; Yoon KS; Ha J; Kang I; Choe W
    Biochem Biophys Res Commun; 2021 May; 552():44-51. PubMed ID: 33743348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bile acids increase levels of microRNAs 221 and 222, leading to degradation of CDX2 during esophageal carcinogenesis.
    Matsuzaki J; Suzuki H; Tsugawa H; Watanabe M; Hossain S; Arai E; Saito Y; Sekine S; Akaike T; Kanai Y; Mukaisho K; Auwerx J; Hibi T
    Gastroenterology; 2013 Dec; 145(6):1300-11. PubMed ID: 23933602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exposure of Barrett's and esophageal adenocarcinoma cells to bile acids activates EGFR-STAT3 signaling axis via induction of APE1.
    Bhat AA; Lu H; Soutto M; Capobianco A; Rai P; Zaika A; El-Rifai W
    Oncogene; 2018 Nov; 37(46):6011-6024. PubMed ID: 29991802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toll-like Receptor 2 Signalling and the Lysosomal Machinery in Barrett's Esophagus.
    Verbeek RE; Siersema PD; Vleggaar FP; Ten Kate FJ; Posthuma G; Souza RF; de Haan J; van Baal JW
    J Gastrointestin Liver Dis; 2016 Sep; 25(3):273-82. PubMed ID: 27689189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of EGFR-DNA-PKcs pathway by IGFBP2 protects esophageal adenocarcinoma cells from acidic bile salts-induced DNA damage.
    Zhou Z; Lu H; Zhu S; Gomaa A; Chen Z; Yan J; Washington K; El-Rifai W; Dang C; Peng D
    J Exp Clin Cancer Res; 2019 Jan; 38(1):13. PubMed ID: 30626422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APE1-mediated DNA damage repair provides survival advantage for esophageal adenocarcinoma cells in response to acidic bile salts.
    Hong J; Chen Z; Peng D; Zaika A; Revetta F; Washington MK; Belkhiri A; El-Rifai W
    Oncotarget; 2016 Mar; 7(13):16688-702. PubMed ID: 26934647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression changes associated with Barrett's esophagus and Barrett's-associated adenocarcinoma cell lines after acid or bile salt exposure.
    Hao Y; Sood S; Triadafilopoulos G; Kim JH; Wang Z; Sahbaie P; Omary MB; Lowe AW
    BMC Gastroenterol; 2007 Jun; 7():24. PubMed ID: 17597535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the interleukin-6/STAT3 antiapoptotic pathway in esophageal cells by bile acids and low pH: relevance to barrett's esophagus.
    Dvorak K; Chavarria M; Payne CM; Ramsey L; Crowley-Weber C; Dvorakova B; Dvorak B; Bernstein H; Holubec H; Sampliner RE; Bernstein C; Prasad A; Green SB; Garewal H
    Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5305-13. PubMed ID: 17875759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bile acid-induced "Minority MOMP" promotes esophageal carcinogenesis while maintaining apoptotic resistance via Mcl-1.
    Xu Y; Surman DR; Diggs L; Xi S; Gao S; Gurusamy D; McLoughlin K; Drake J; Feingold P; Brown K; Wangsa D; Wangsa D; Zhang X; Ried T; Davis JL; Hernandez J; Hoang CD; Souza RF; Schrump DS; Taylor Ripley R
    Oncogene; 2020 Jan; 39(4):877-890. PubMed ID: 31570787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Honokiol activates LKB1-miR-34a axis and antagonizes the oncogenic actions of leptin in breast cancer.
    Avtanski DB; Nagalingam A; Bonner MY; Arbiser JL; Saxena NK; Sharma D
    Oncotarget; 2015 Oct; 6(30):29947-62. PubMed ID: 26359358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Honokiol abrogates lipopolysaccharide-induced depressive like behavior by impeding neuroinflammation and oxido-nitrosative stress in mice.
    Sulakhiya K; Kumar P; Jangra A; Dwivedi S; Hazarika NK; Baruah CC; Lahkar M
    Eur J Pharmacol; 2014 Dec; 744():124-31. PubMed ID: 25446914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-Myc is a novel target of cell cycle arrest by honokiol in prostate cancer cells.
    Hahm ER; Singh KB; Singh SV
    Cell Cycle; 2016 Sep; 15(17):2309-20. PubMed ID: 27341160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Honokiol inhibits breast cancer cell metastasis by blocking EMT through modulation of Snail/Slug protein translation.
    Wang WD; Shang Y; Li Y; Chen SZ
    Acta Pharmacol Sin; 2019 Sep; 40(9):1219-1227. PubMed ID: 31235819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti‑proliferative effect of honokiol on SW620 cells through upregulating BMP7 expression via the TGF‑β1/p53 signaling pathway.
    Li Q; Ma Y; Liu XL; Mu L; He BC; Wu K; Sun WJ
    Oncol Rep; 2020 Nov; 44(5):2093-2107. PubMed ID: 32901874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.